Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1205
831. SAKS VA AND ALIEV MK. Is there the creatine kinase equilibrium
in working heart cells? Biochem Biophys Res Commun 227: 360–
367, 1996.
832. SAKS VA, BELIKOVA YO, KUZNETSOV AV, KHUCHUA ZA,
BRANISHTE TH, SEMENOVSKY ML, AND NAUMOV VG. Phosphocreatine
pathway for energy transport: ADP diffusion and cardiomyopathy.
Am J Physiol Suppl 261: 30–38, 1991.
833. SAKS VA, BOBKOV YG, AND STRUMIA EDS E. Creatine Phosphate:
Biochemistry, Pharmacology and Clinical Efficiency.
Torino, Italy: Edizioni Minerva Medica, 1987.
834. SAKS VA, JAVADOV SA, POZIN E, AND PREOBRAZHENSKY AN.
Biochemical basis of the protective action of phosphocreatine on
the ischemic myocardium. In: Creatine Phosphate: Biochemistry,
Pharmacology and Clinical Efficiency, edited by V. A. Saks, Y. G.
Bobkov, and E. Strumia. Torino, Italy: Edizioni Minerva Medica,
1987, p. 95–111.
835. SAKS VA, KAPELKO VI, KUPRIYANOV VV, KUZNETSOV AV,
LAKOMKIN VL, VEKSLER VI, SHAROV VG, JAVADOV SA, SEP-
PET EK, AND KAIRANE C. Quantitative evaluation of relationship
between cardiac energy metabolism and post-ischemic recovery
of contractile function. J Mol Cell Cardiol 21 Suppl I: 67–78, 1989.
836. SAKS VA AND STRUMIA E. Phosphocreatine: molecular and cellular
aspects of the mechanism of cardioprotective action. Curr
Ther Res 53: 565–598, 1993.
837. SAKS VA, VENTURA-CLAPIER R, AND ALIEV MK. Metabolic control
and metabolic capacity: two aspects of creatine kinase functioning
in the cells. Biochim Biophys Acta 1274: 81–88, 1996.
838. SAKS VA, VENTURA-CLAPIER R, LEVERVE X, RIGOULET M,
AND ROSSI A, Eds. Bioenergetics of the cell: quantitative aspects.
Mol Cell Biochem 184: 1–460, 1998.
839. SALMON CP, KNIZE MG, AND FELTON JS. Effects of marinating
on heterocyclic amine carcinogen formation in grilled chicken.
Food Chem Toxicol 35: 433–441, 1997.
840. SALTARELLI MD, BAUMAN AL, MOORE KR, BRADLEY CC, AND
BLAKELY RD. Expression of the rat brain creatine transporter in
situ and in transfected HeLa cells. Dev Neurosci 18: 524–534,
1996.
841. SANBE A, TANONAKA K, KOBAYASI R, AND TAKEO S. Effects of
long-term therapy with ACE inhibitors, captopril, enalapril and
trandolapril, on myocardial energy metabolism in rats with heart
failure following myocardial infarction. J Mol Cell Cardiol 27:
2209–2222, 1995.
842. SANDBERG AA, HECHT HH, AND TYLER FH. Studies in disorders
of muscle. X. The site of creatine synthesis in the human. Metabolism
2: 22–29, 1953.
843. SANDOVAL N, BAUER D, BRENNER V, COY JF, DRESCHER B,
KIOSCHIS P, KORN B, NYAKATURA G, POUSTKA A, REICH-
WALD K, ROSENTHAL A, AND PLATZER M. The genomic organization
of a human creatine transporter (CRTR) gene located in
Xq28. Genomics 35: 383–385, 1996.
844. SANT’ANA PEREIRA JAA, SARGEANT AJ, RADEMAKER ACHJ,
DE HAAN A, AND VAN MECHELEN W. Myosin heavy chain isoform
expression and high energy phosphate content in human
muscle fibres at rest and post-exercise. J Physiol (Lond) 496:
583–588, 1996.
845. SANYAL R, DARROUDI F, PARZEFALL W, NAGAO M, AND KNAS-
MÜLLER S. Inhibition of the genotoxic effects of heterocyclic
amines in human derived hepatoma cells by dietary bioantimutagens.
Mutagenesis 12: 297–303, 1997.
846. SATOH S, TANAKA A, HATANO E, INOMOTO T, IWATA S, KITAI
T, SHINOHARA H, TSUNEKAWA S, CHANCE B, AND YAMAOKA
Y. Energy metabolism and regeneration in transgenic mouse liver
expressing creatine kinase after major hepatectomy. Gastroenterology
110: 1166–1174, 1996.
847. SATOLLI F AND MARCHESI G. Creatine phosphate in the rehabilitation
of patients with muscle hypotonotrophy of the lower extremity.
Curr Ther Res 46: 67–73, 1989.
848. SAUPE KW, SPINDLER M, TIAN R, AND INGWALL JS. Impaired
cardiac energetics in mice lacking muscle-specific isoenzymes of
creatine kinase. Circ Res 82: 898–907, 1998.
849. SAUTER A AND RUDIN M. Determination of creatine kinase kinetic
parameters in rat brain by NMR magnetization transfer.
Correlation with brain function. J Biol Chem 268: 13166–13171,
1993.
850. SAVABI F. Free creatine available to the creatine phosphate energy
shuttle in isolated rat atria. Proc Natl Acad Sci USA 85:
7476–7480, 1988.
851. SAVABI F. Mitochondrial creatine phosphokinase deficiency in
diabetic rat heart. Biochem Biophys Res Commun 154: 469–475,
1988.
852. SAVABI F AND BESSMAN SP. Postanoxic recovery of spontaneously
beating isolated atria: pH related role of adenylate kinase.
Biochem Med Metab Biol 35: 345–355, 1986.
853. SAVABI F AND BESSMAN SP. Recovery of isolated rat atrial
function related to ATP under different anoxic conditions. Arch
Biochem Biophys 248: 151–157, 1986.
854. SAVABI F AND KIRSCH A. Alteration of the phosphocreatine energy
shuttle components in diabetic rat heart. J Mol Cell Cardiol
23: 1323–1333, 1991.
855. SCATTOLIN G, GABELLINI A, DESIDERI A, FORMICHI M, CAN-
EVE F, AND CORBARA F. Diastolic function and creatine phosphate:
an echocardiographic study. Curr Ther Res 54: 562–571,
1993.
856. SCHAEFER S, GOBER JR, SCHWARTZ GG, TWIEG DB, WEINER
MW, AND MASSIE B. In vivo phosphorus-31 spectroscopic imaging
in patients with global myocardial disease. Am J Cardiol 65:
1154–1161, 1990.
857. SCHIFFENBAUER YS, MEIR G, COHN M, AND NEEMAN M. Cyclocreatine
transport and cytotoxicity in rat glioma and human
ovarian carcinoma cells: 31 P-NMR spectroscopy. Am J Physiol
Cell Physiol 270: C160–C169, 1996.
858. SCHIFFENBAUER YS, TEMPEL C, ABRAMOVITCH R, MEIR G,
AND NEEMAN M. Cyclocreatine accumulation leads to cellular
swelling in C6 glioma multicellular spheroids: diffusion and onedimensional
chemical shift nuclear magnetic resonance microscopy.
Cancer Res 55: 153–158, 1995.
859. SCHIMMEL L, KHANDEKAR VS, MARTIN KJ, RIERA T, HONAN
C, SHAW DG, AND KADDURAH-DAOUK R. The synthetic phosphagen
cyclocreatine phosphate inhibits the growth of a broad spectrum
of solid tumors. Anticancer Res 16: 375–380, 1996.
860. SCHLOSS P, MAYSER W, AND BETZ H. The putative rat choline
transporter CHOT1 transports creatine and is highly expressed in
neural and muscle-rich tissues. Biochem Biophys Res Commun
198: 637–645, 1994.
861. SCHMITT T AND PETTE D. Increased mitochondrial creatine kinase
in chronically stimulated fast-twitch rabbit muscle. FEBS
Lett 188: 341–344, 1985.
862. SCHOENMAKERS CHH, KULLER T, LINDEMANS J, AND BLIJEN-
BERG BG. Automated enzymatic methods for creatinine measurement
with special attention to bilirubin interference. Eur J Clin
Chem Clin Biochem 31: 861–868, 1993.
863. SCHULTHEISS H-P, SCHULZE K, SCHAUER R, WITZEN-
BICHLER B, AND STRAUER BE. Antibody-mediated imbalance of
myocardial energy metabolism. A causal factor of cardiac failure?
Circ Res 76: 64–72, 1995.
864. SCHULTHEISS K, THATE A, AND MEYER DK. Effects of creatine
on synthesis and release of �-[ 3 H]aminobutyric acid. J Neurochem
54: 1858–1863, 1990.
865. SCHULTZ D, SU X, BISHOP SP, BILLADELLO J, AND DELL’ITALIA
LJ. Selective induction of the creatine kinase-B gene in chronic
volume overload hypertrophy is not affected by ACE-inhibitor
therapy. J Mol Cell Cardiol 29: 2665–2673, 1997.
866. SCHULZ JB, HENSHAW DR, MACGARVEY U, AND BEAL MF.
Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.
Neurochem Int 29: 167–171, 1996.
867. SCHULZE A, HESS T, WEVERS R, MAYATEPEK E, BACHERT P,
MARESCAU B, KNOPP MV, DE DEYN PP, BREMER HJ, AND
RATING D. Creatine deficiency syndrome caused by guanidinoacetate
methyltransferase deficiency: diagnostic tools for a new
inborn error of metabolism. J Pediatr 131: 626–631, 1997.
868. SCHULZE A, MAYATEPEK E, BACHERT P, MARESCAU B, DE
DEYN PP, AND RATING D. Therapeutic trial of arginine restriction
in creatine deficiency syndrome. Eur J Pediatr 157: 606–607,
1998.